You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
智雲健康遞交上市申請,傳集資最多38.8億
uSMART盈立智投 08-27 19:54

中國慢病管理解決方案供應商智雲健康科技(ClouDr)遞交上市申請,摩根士丹利及摩根大通爲聯席保薦人。早前有外電報道指,公司計劃集資4億至5億美元(摺合約31億至38.8億港元)。

智雲健康圍繞慢病管理,向醫院、藥店以及個人提供解決方案,包括銷售醫療器械、耗材,以滿足醫院對患者慢病管理的需求。而公司的醫院SaaS產品,能透過自主研發的AIoT設備,與其銷售的部分醫療器械相連。面向製藥公司,則有數字營銷服務提供。

公司去年全年收入達8.39億元人民幣,按年增長60%;根據非國際財務報告準則衡量的調整後淨虧損爲6.36億元人民幣,按年擴大3.3倍。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account